Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy

Epilepsia

Volumn 51, Issue 5, 2010, Pages 797-804

  Canevini, Maria Paola ^a   De Sarro, Giovambattista ^b   Galimberti, Carlo Andrea ^c   Gatti, Giuliana ^d   Licchetta, Laura ^e   Malerba, Ambra ^d   Muscas, Giancarlo ^f   La Neve, Angela ^g   Striano, Pasquale ^h   Perucca, Emilio ^c,d   Baruzzi, Agostino ^e   Bonizzoni, Erminio ^d   Fattore, Cinzia ^c,d   Franco, Valentina ^d   Marzanatti, Mario ^d   Mazzucchelli, Iolanda ^d   Alexandre, Veriano ^c,i   Ambrosio, Roberta ^b   Beccaria, Francesca ^j   Bisulli, Francesca ^e   Cagdas, Sophie ^j   Capovilla, Giuseppe ^j   Ciampa, Clotilde ^k   De Fazio, Salvatore ^b   Errichiello, Luca ^k   Frassine, Benedetta ^j,l   Gambardella, Antonio ^b   Gana, Simone ^m   Giordano, Lucio ^l   Guerrini, Renzo ^m,n   La Briola, Francesca ^a   Ladogana, Marianna ^g   Lamberti, Paolo ^g   Papantonio, Anna Maria ^o   Pascarella, Angelo ^k   Pellacani, Simona ^m   Rosati, Eleonora ^f   Santulli, Lia ^k   Specchio, Luigi Maria ^o   Striano, Salvatore ^k   Tiberti, Alessandra ^l   Tinuper, Paolo ^e   Tozzi, Rossana ^c   Trivisano, Marina ^o   more..

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f CAREGGI UNIVERSITY HOSPITAL   (Italy)

^g UNIVERSITY OF BARI   (Italy)

^h G GASLINI INSTITUTE   (Italy)

ⁱ UNIVERSITY OF SÃO PAULO   (Brazil)

^j CARLO POMA HOSPITAL   (Italy)

^k UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^l SPEDALI CIVILI   (Italy)

^m UNIVERSITY OF FLORENCE   (Italy)

ⁿ DEPARTMENT OF DEVELOPMENTAL NEUROSCIENCE   (Italy)

^o UNIVERSITY OF FOGGIA   (Italy)

more..

Author keywords

Adverse effects; Antiepileptic drugs; Drug load; Drug resistance; Epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; CONCENTRATION LOSS; DIPLOPIA; EPILEPSY; FATIGUE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MONOTHERAPY; NERVOUSNESS; PATIENT REFERRAL; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SIDE EFFECT; SOMNOLENCE; TREMOR; WEIGHT GAIN;

EID: 77951561572     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02520.x     Document Type: Article

References (41)

1. Alexandre V Jr, Capovilla G, De Fazio S, Fattore C, Franco V, Guerrini R, Francesca La Briola F, Ladogana M, Rosati E, Specchio LM, Striano S, Perucca E on behalf of the SOPHIE Study Group. (2010) Characteristics of a large population of patients with refractory epilepsy attending tertiary referral centres in Italy. Epilepsia February 3 [Epub ahead of print] doi: 10.1111/j.1528-1167.2009.02512.x.
2. Baker GA, Frances P, Middleton E, Jacoby A, Schaper GJ, Defalla B, Young C, Smith DF, Chadwick DW. (1994) Initial development, reliability, and validity of a patient-based adverse event scale. Epilepsia 35(suppl 7):80.
3. Baker GA, Jacoby A, Buck D, Stalgis C, Monnet D. (1997) Quality of life of people with epilepsy: a European study. Epilepsia 38:353-362. (Pubitemid 27147650)
4. Baker GA, Camfield C, Camfield P, Cramer JA, Elger CE, Johnson AL, Martins da Silva A, Meinardi H, Munari C, Perucca E, Thorbeke R. (1998) Commission on outcome measurement in epilepsy, 1994-1997: final report. Epilepsia 39:213-231. (Pubitemid 28074359)
5. Beck AT, Steer RA, Ball R, Ranieri W. (1996) Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J Pers Assess 67:588-597. (Pubitemid 26382973)
6. Beghi E, Gatti G, Tonini C, Ben-Menachem E, Chadwick DW, Nikanorova M, Gromov SA, Smith PE, Specchio LM, Perucca E; BASE Study Group. (2003) Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial. Epilepsy Res 57:1-13. (Pubitemid 38045463)
7. Brodie MJ, Yuen AW. (1997) Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group. Epilepsy Res 26:423-432.
8. Carreño M, Gil-Nagel A, Sánchez JC, Elices E, Serratosa JM, Salas-Puig J, Villanueva V, Porcel J. (2008) Strategies to detect adverse effects of antiepileptic drugs in clinical practice. Epilepsy Behav 13:178-183.
9. Choi-Kwon S, Chung C, Kim H, Lee S, Yoon S, Kho H, Oh J, Lee S. (2003) Factors affecting the quality of life in patients with epilepsy in Seoul, South Korea. Acta Neurol Scand 108:428-434. (Pubitemid 37464123)
10. Cramer JA, Hammer AE, Kustra RP. (2004) Quality of life improvement with conversion to lamotrigine monotherapy. Epilepsy Behav 5:224-230. (Pubitemid 38461212)
11. Cramer JA, Brandenburg NA, Xu X, Vera-Llonch M, Oster G. (2007) The impact of seizures and adverse effects on global health ratings. Epilepsy Behav 11:179-184. (Pubitemid 47279105)
12. Deckers CL, Hekster YA, Keyser A, Meinardi H, Renier WO. (1997) Reappraisal of polytherapy in epilepsy: a critical review of drug load and adverse effects. Epilepsia 38:570-575. (Pubitemid 27199912)
13. Deckers CL, Czuczwar SJ, Hekster YA, Keyser A, Kubova H, Meinardi H, Patsalos PN, Renier WO, Van Rijn CM. (2000) Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia 41:1364-1374.
14. Deckers CL, Hekster YA, Keyser A, van Lier HJ, Meinardi H, Renier WO. (2001) Monotherapy versus polytherapy for epilepsy: a multicenter double-blind randomized study. Epilepsia 42:1387-1394. (Pubitemid 33140612)
15. Evans BK, Kustra RF, Hammer AE. (2007) Assessment of tolerability in elderly patients: changing to lamotrigine therapy. Am J Geriatr Pharmacother 5:112-119. (Pubitemid 47264114)
16. Gilliam FG, Fessler AJ, Baker G, Vahle V, Carter J, Attarian H. (2004) Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 62:23-27. (Pubitemid 38082864)
17. Guekht AB, Mitrokhina TV, Lebedeva AV, Dzugaeva FK, Milchakova LE, Lokshina OB, Feygina AA, Gusev EI. (2007) Factors influencing on quality of life in people with epilepsy. Seizure 16:128-133. (Pubitemid 46222211)
18. Jacoby A, Gamble C, Doughty J, Marson A, Chadwick D; Medical Research Council MESS Study Group. (2007) Quality of life outcomes of immediate or delayed treatment of early epilepsy and single seizures. Neurology 68:1188-1196.
19. Jonker DM, Voskuyl RA, Danhof M. (2007) Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments? Epilepsia 48:412-434.
20. Kaminski RM, Matagne A, Patsalos PN, Klitgaard H. (2009) Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam. Epilepsia 50:387-397.
21. Kustra RP, Meador KJ, Evans BK, Leschek-German LM, Groenke DA, Hammer AE, Nanry KP, Messenheimer JA. (2005) Lamotrigine therapy in patients requiring a change in antiepileptic drug regimen. Seizure 14:254-261.
22. Kwan P, Brodie MJ. (2000) Early identification of refractory epilepsy. N Engl J Med 342:314-319.
23. Kwan P, Brodie MJ. (2006) Combination therapy in epilepsy: when and what to use. Drugs 66:1817-1829. (Pubitemid 44584005)
24. Lammers MW, Hekster YA, Keyser A, Meinardi H, Renier WO, van Lier H. (1995) Monotherapy or polytherapy for epilepsy revisited: a quantitative assessment. Epilepsia 36:440-446.
25. Meldolesi GN, Picardi A, Quarato PP, Grammaldo LG, Esposito V, Mascia A, Sparano A, Morosini P, Di Gennaro G. (2006) Factors associated with generic and disease-specific quality of life in temporal lobe epilepsy. Epilepsy Res 69:135-146.
26. Panelli RJ, Kilpatrick C, Moore SM, Matkovic Z, D'Souza W, O'Brien TJ. (2007) The Liverpool adverse events profile: relation to AED use and mood. Epilepsia 48:456-463. (Pubitemid 46365186)
27. Patsalos PN, Berry DJ, Bourgeois BFD, Cloyd JC, Glauser TA, Johannessen SI, Leppik I, Tomson T, Perucca E. (2008) Antiepileptic drugs - Best practice guidelines for therapeutic drug monitoring: a position paper by the Subcommission on Therapeutic Drug Monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 49:1239-1276.
28. Perucca E. (1998) Pharmacoresistance in epilepsy: How should it be defined? CNS Drugs 10:171-179.
29. Perucca E, Beghi E, Dulac O, Shorvon S, Tomson T. (2000) Assessing risk to benefit ratio in antiepileptic drug therapy. Epilepsy Res 41:107-139. (Pubitemid 30625026)
30. Perucca E, Dulac O, Shorvon S, Tomson T. (2001) Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation. CNS Drugs 15:609-621. (Pubitemid 32848342)
31. Perucca E, Kwan P. (2005) Overtreatment in epilepsy: how it occurs and how it can be avoided. CNS Drugs 19:897-908. (Pubitemid 41571990)
32. Piazzini A, Ramaglia G, Turner K, Chifari R, Kiky EE, Canger R, Canevini MP. (2007) Coping strategies in epilepsy: 50 drug-resistant and 50 seizure-free patients. Seizure 16:211-217. (Pubitemid 46336816)
33. Piazzini A, Beghi E, Turner K, Ferraroni M; LICE Quality of Life Group. (2008) Health-related quality of life in epilepsy: findings obtained with a new Italian instrument. Epilepsy Behav 13:119-126.
34. Piperidou C, Karlovasitou A, Triantafyllou N, Dimitrakoudi E, Terzoudi A, Mavraki E, Trypsianis G, Vadikolias K, Heliopoulos I, Vassilopoulos D, Balogiannis S. (2008) Association of demographic, clinical and treatment variables with quality of life in patients with epilepsy in Greece. Qual Life Res 17:987-996.
35. Pirio Richardson S, Farias ST, Lima AR 3rd, Alsaadi TM. (2004) Improvement in seizure control and quality of life in medically refractory epilepsy patients converted from polypharmacy to monotherapy. Epilepsy Behav 5:343-347. (Pubitemid 38950094)
36. Pisani F, Oteri G, Russo MF, Di Perri R, Perucca E, Richens A. (1999) The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction. Epilepsia 40:1141-1146. (Pubitemid 29372631)
37. Reynolds EH, Shorvon SD. (1977) Unnecessary polypharmacy for epilepsy. Br Med J 1:1635-1637.
38. Szaflarski JP, Hughes C, SzaflarskiM, Ficker DM, Cahill WT, Li M, Privitera MD. (2003) Quality of life in psychogenic nonepileptic seizures. Epilepsia 44:236-242. (Pubitemid 36206028)
39. Téllez-Zenteno JF, Dhar R, Hernandez-Ronquillo L, Wiebe S. (2007) Long-term outcomes in epilepsy surgery: antiepileptic drugs, mortality, cognitive and psychosocial aspects. Brain 130(Pt 2):334-345. (Pubitemid 46181088)
40. Thomas SV, Koshy S, Nair CR, Sarma SP. (2005) Frequent seizures and polytherapy can impair quality of life in persons with epilepsy. Neurol India 53:46-50. (Pubitemid 40545196)
41. World Health Organization Collaborating Centre for Drug Statistics Methodology